IBUPROFEN DISPOSITION IN OBESE INDIVIDUALS

被引：45
作者：
ABERNETHY, DR [1 ]
GREENBLATT, DJ [1 ]
机构：
[1] TUFTS UNIV,NEW ENGLAND MED CTR,DIV CLIN PHARMACOL,BOSTON,MA 02111
来源：
ARTHRITIS AND RHEUMATISM | 1985年 / 28卷 / 10期
关键词：
D O I：
10.1002/art.1780281006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1117 / 1121
页数：5
相关论文
共 30 条
  • [1] THE INFLUENCE OF OBESITY ON THE PHARMACOKINETICS OF ORAL ALPRAZOLAM AND TRIAZOLAM
    ABERNETHY, DR
    GREENBLATT, DJ
    DIVOLL, M
    SMITH, RB
    SHADER, RI
    [J]. CLINICAL PHARMACOKINETICS, 1984, 9 (02) : 177 - 183
  • [2] ABERNETHY DR, 1983, J LAB CLIN MED, V101, P873
  • [3] ABERNETHY DR, 1984, AM J GASTROENTEROL, V79, P91
  • [4] OBESITY, SEX, AND ACETAMINOPHEN DISPOSITION
    ABERNETHY, DR
    DIVOLL, M
    GREENBLATT, DJ
    AMEER, B
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (06) : 783 - 790
  • [5] ABERNETHY DR, 1984, J CLIN PHARMACOL, V24, P409
  • [6] ABERNETHY DR, 1981, J PHARMACOL EXP THER, V217, P681
  • [7] LIDOCAINE DISPOSITION IN OBESITY
    ABERNETHY, DR
    GREENBLATT, DJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (08) : 1183 - 1186
  • [8] PHARMACOKINETICS OF DRUGS IN OBESITY
    ABERNETHY, DR
    GREENBLATT, DJ
    [J]. CLINICAL PHARMACOKINETICS, 1982, 7 (02) : 108 - 124
  • [9] ADAMS SS, 1969, ARCH INT PHARMACOD T, V178, P115
  • [10] ALBERT KS, 1984, AM J MED, V77, P47, DOI 10.1016/S0002-9343(84)80018-2
123